A Phase I/II Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures

Trial Profile

A Phase I/II Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 17 May 2017

At a glance

  • Drugs ICX-RHY (Primary)
  • Indications Scars; Skin disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Dec 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 27 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top